The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Alarm Therapy for Nocturnal Enuresis in Children

First-line behavioral treatment for primary monosymptomatic nocturnal enuresis in children over 6 years, using a moisture-sensitive alarm to wake the child at the onset of wetting and condition arousal and bladder control, achieving high long-term cure rates with proper adherence.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Çocuk Sağlığı ve Hastalıkları department. Book Appointment →

What is Alarm Therapy for Nocturnal Enuresis in Children?

Alarm therapy is a behavioral conditioning treatment for primary monosymptomatic nocturnal enuresis (bedwetting without daytime urinary symptoms) in children typically 6 years or older, in which a moisture sensor placed in underwear or under a sheet triggers an audible or vibratory alarm at the onset of urine release, gradually conditioning the child to wake to bladder distension before voiding.

Mechanism involves classical and operant conditioning that increases nocturnal arousal threshold, enhances bladder storage capacity, and integrates pelvic floor responses, leading to dry nights that persist after the alarm is discontinued in approximately two-thirds of children with sustained 14-night dry response.

Treatment is delivered with structured family education, daily voiding and drinking schedules, motivational support, response monitoring, and a planned 8–16 week trial; addition of desmopressin or anticholinergics is considered in partial responders or in households unable to commit fully to alarm protocol.

Symptoms

Bedwetting at least 1–2 nights per week in a child older than 5–6 years
Absence of daytime wetting, urgency, frequency, or constipation (monosymptomatic enuresis)
Family history of bedwetting in parents or siblings
Heavy sleep with difficulty in arousing the child during nocturnal voiding
Possible psychosocial impact: low self-esteem, social withdrawal, sleepover avoidance
Coexisting constipation, attention deficit hyperactivity disorder, or anxiety in nonmonosymptomatic forms

Risk Factors

Family history of nocturnal enuresis with autosomal dominant inheritance pattern
Delayed bladder maturation, nocturnal polyuria from low antidiuretic hormone secretion
Reduced functional bladder capacity at night
Constipation increasing bladder pressure and reducing capacity
Sleep disorders, including obstructive sleep apnea and parasomnias
Psychological stress, family disruption, recent life events

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Child older than 5–6 years with persistent bedwetting affecting self-esteem or family — pediatric or pediatric urology consultation
  • New onset secondary enuresis after a dry period — evaluation for diabetes, urinary tract infection, constipation, or psychosocial stressors
  • Daytime wetting, urgency, dysuria, or constipation alongside nocturnal enuresis — assessment for nonmonosymptomatic enuresis with structured history and exam
  • Failed alarm therapy after 12–16 weeks of consistent use — review and consider combination therapy
  • Significant family or psychological distress — collaborative care with pediatric mental health support

Treatment Methods

01
Structured education for child and family about bladder physiology, normal expected dry-night progression, and rationale of alarm therapy
02
Daytime voiding schedule (every 2–3 hours), regular fluid intake, evening fluid restriction, and management of constipation
03
Bedwetting alarm worn nightly for 8–16 weeks, with prompt waking, walking to toilet, completion of voiding, and resetting of alarm; family must be ready to assist during initial weeks
04
Continued use until 14 consecutive dry nights, with follow-up monitoring and possible re-treatment in case of relapse
05
Combination therapy with desmopressin in nocturnal polyuria patients or short-term coverage during travel or camp; anticholinergics for reduced bladder capacity in selected cases

Which Department to Visit?

You can visit our Çocuk Sağlığı ve Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Çocuk Sağlığı ve Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Regular Gynecological Check-up

Kadın Hastalıkları ve Doğum

Regular gynecological check-ups enable early diagnosis of many women's diseases and increase treatment success. It is recommended that every sexually active woman or woman over 21 see a gynecologist at least once a year.

Cervical Cancer

Kadın Hastalıkları ve Doğum

Cervical cancer develops from uncontrolled growth of cells in the cervix and is among the most common women's cancers worldwide. Precancerous lesions can be recognized with regular Pap smear and HPV testing.

HPV and Vaccination

Kadın Hastalıkları ve Doğum

HPV is a common virus transmitted sexually that can lead to certain types of cancer. Vaccination provides over 90% protection against high-risk HPV strains.

Ovarian Cyst

Kadın Hastalıkları ve Doğum

Ovarian cysts are fluid-filled sacs that form in or on the ovarian tissue. Most are asymptomatic and disappear spontaneously; however, large or complex cysts can cause pain and complications.

Endometriosis

Kadın Hastalıkları ve Doğum

Endometriosis affects about 10% of women of reproductive age, causing cyclic pelvic pain, dysmenorrhea, dyspareunia, and infertility; combined medical and laparoscopic treatment improves quality of life.

Uterine Fibroids

Kadın Hastalıkları ve Doğum

Uterine fibroids are benign tumors developing from the uterine muscle layer. They affect 20-50% of women of reproductive age; most are asymptomatic, but can cause bleeding and pain.

Polycystic Ovary Syndrome (PCOS)

Kadın Hastalıkları ve Doğum

PCOS is the most common endocrine disease affecting approximately 10% of women of reproductive age, characterized by androgen excess, ovulation disorder, and polycystic ovarian appearance.

Menopause

Kadın Hastalıkları ve Doğum

Menopause is the life stage defined by not having a period for 12 consecutive months and the natural cessation of ovarian function. The average age is 51, but it can vary between 45-55 years.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.